---
title: Novel developments in the prophylaxis and treatment of acute GVHD
date: '2023-07-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37471585/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20230720211416&v=2.17.9.post6+86293ac
source: Blood
description: Acute graft-versus-host disease (GVHD) is a major life-threatening complication
  after allogeneic hematopoietic cell transplantation (allo-HCT). Traditional standard
  prophylaxis for acute GVHD has included a calcineurin-inhibitor plus an antimetabolite,
  while treatment has relied mainly on corticosteroids followed by multiple non-standard
  second line options. In the last decade this basic framework has been reshaped by
  approval of ATG products, the emergence of post-transplant ...
disable_comments: true
---
Acute graft-versus-host disease (GVHD) is a major life-threatening complication after allogeneic hematopoietic cell transplantation (allo-HCT). Traditional standard prophylaxis for acute GVHD has included a calcineurin-inhibitor plus an antimetabolite, while treatment has relied mainly on corticosteroids followed by multiple non-standard second line options. In the last decade this basic framework has been reshaped by approval of ATG products, the emergence of post-transplant ...